Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isoprenaline hydrochloride |
Is a |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Accidental overdose of isoprenaline |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Allergy to isoprenaline |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
|
allergi over for isoprenalin til oral anvendelse |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
|
allergi over for inhaleret isoprenalin |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
|
allergi over for isoprenalin til parenteral anvendelse |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline overdose |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Intentional overdose of isoprenaline |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
overdosis af isoprenalin, uvist med hvilken hensigt |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
isoproterenolhydrochlorid 2 mg/2 ml koncentrat til infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Product containing isoprenaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
isoproterenol til inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Isoprenaline sulfate |
Is a |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, flaske a 125 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline adverse reaction |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Oral isoprenaline adverse reaction |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Inhaled isoprenaline adverse reaction |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Parenteral isoprenaline adverse reaction |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
natriumcromglycat + isoprenalinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
allergi over for isoprenalin til oral anvendelse |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
Allergy to isoprenaline |
Causative agent |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
allergi over for isoprenalin til parenteral anvendelse |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
allergi over for inhaleret isoprenalin |
Causative agent |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
Isoprenaline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Isoprenaline |
Inferred relationship |
Some |
|
Product containing cromoglicic acid and isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
2 |
Cromoglicic acid and isoprenaline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
2 |
Product containing only isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing only isoprenaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing only isoprenaline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |